APA

Mease P., Husni M. E., Kafka S., Chakravarty S. D., Harrison D. D., Lo K. H., Xu S., Hsia E. C. & Kavanaugh A. (20210111). Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial. : Arthritis research & therapy.

Chicago

Mease Philip, Husni M Elaine, Kafka Shelly, Chakravarty Soumya D, Harrison Diane D, Lo Kim Hung, Xu Stephen, Hsia Elizabeth C and Kavanaugh Arthur. 20210111. Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial. : Arthritis research & therapy.

Harvard

Mease P., Husni M. E., Kafka S., Chakravarty S. D., Harrison D. D., Lo K. H., Xu S., Hsia E. C. and Kavanaugh A. (20210111). Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial. : Arthritis research & therapy.

MLA

Mease Philip, Husni M Elaine, Kafka Shelly, Chakravarty Soumya D, Harrison Diane D, Lo Kim Hung, Xu Stephen, Hsia Elizabeth C and Kavanaugh Arthur. Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial. : Arthritis research & therapy. 20210111.